Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-26 Purchase |
2025-06-30 4:56 pm |
Cidara Therapeutics Inc. | CDTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,272,727 | $44 | $99,999,988 | 3,365,523 (Indirect) |
View |
| 2025-06-12 Purchase |
2025-06-16 8:06 pm |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
163,287 | $10.19 | $1,664,700 | 12,198,625 (Indirect) |
View |
| 2025-06-09 Purchase |
2025-06-11 7:44 pm |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
186,850 | $10.19 | $1,904,002 | 12,035,338 (Indirect) |
View |
| 2025-06-04 Purchase |
2025-06-06 4:43 pm |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,211,198 | $9.7022 | $11,751,304 | 11,848,488 (Indirect) |
View |
| 2025-05-12 Purchase |
2025-05-14 6:08 pm |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
536,426 | $0.90821 | $487,188 | 6,681,307 (Indirect) |
View |
| 2025-03-13 Purchase |
2025-03-17 7:56 pm |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,296,296 | $13.5 | $17,499,996 | 6,147,280 (Indirect) |
View |
| 2025-03-05 Purchase |
2025-03-07 6:05 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
824,041 | $30.75 | $25,342,965 | 11,189,693 (Indirect) |
View |
| 2025-02-10 Purchase |
2025-02-10 5:04 pm |
Sionna Therapeutics Inc. | SION | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,125,000 | $18 | $20,250,000 | 2,324,498 (Indirect) |
View |
| 2025-01-30 Purchase |
2025-02-03 5:38 pm |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,714,285 | $8.75 | $49,999,994 | 19,889,683 (Indirect) |
View |
| 2024-11-08 Purchase |
2024-11-13 5:00 pm |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,220,681 | $16.25 | $19,836,066 | 10,637,290 (Indirect) |
View |
| 2024-10-28 Purchase |
2024-10-30 6:12 pm |
Septerna Inc. | SEPN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
4,170,000 | $18 | $75,060,000 | 1,471,943 (Indirect) |
View |
| 2024-10-18 Purchase |
2024-10-22 4:20 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,200,000 | $44.75 | $53,700,000 | 10,365,652 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion